Changing epidemiology of Helicobacter pylori in Japan

Gastric Cancer

Volumn 20, Issue , 2017, Pages 3-7

  Inoue, Manami ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

Epidemiology; Gastric cancer; Helicobacter pylori; Japan

Indexed keywords

AGE DISTRIBUTION; AGING; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; DISEASE ASSOCIATION; ECONOMIC DEVELOPMENT; ENVIRONMENTAL SANITATION; EPIDEMIOLOGICAL DATA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; PREVALENCE; STOMACH CANCER; TREND STUDY; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; TRANSMISSION;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; PREVALENCE;

EID: 84991666850     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-016-0658-5     Document Type: Article

References (22)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F, GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013.
2. Vital Statistics. The Minsitry of Health, Labour, Welfare, Japan.
3. Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, Soda M, Ioka A, Sobue T, Nishimoto H. An updated report on the trends in cancer incidence and mortality in Japan, 1958–2013. Jpn J Clin Oncol. 2015;45:390–401.
4. Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, Japan Cancer Surveillance Research G. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.
5. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, Group WHOIAfRoCMW. A review of human carcinogens—Part B: biological agents. Lancet Oncol. 2009;10:321–2.
6. IARC. A Review of Human Carcinogens. B. Biological Agents. Lyon: WHO Press; 2012.
7. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
8. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.
9. IARC. IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a strategy for preventing gastric cancer. In: IARC Working Group reports volume 8. Lyon: international Agency for Research on Cancer; 2014. pp. 1–181.
10. Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59:1698–709.
11. Matsuhisa T. The trend of Helicobacter pylori infection rate: time, region, race and strain. Helicobacter Res. 2015;19:469–80.
12. Lim SH, Kwon JW, Kim N, Kim GH, Kang JM, Park MJ, Yim JY, Kim HU, Baik GH, Seo GS, Shin JE, Joo YE, Kim JS, Jung HC. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol. 2013;13:104.
13. Wu CY, Lin JT. The changing epidemiology of Asian digestive cancers: from etiologies and incidences to preventive strategies. Best Pract Res Clin Gastroenterol. 2015;29:843–53.
14. Drumm B, Rowland M. The epidemiology of Helicobacter pylori: where to from here? J Pediatr Gastroenterol Nutr. 2003;36:7–8.
15. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.
16. Ueda J, Gosho M, Inui Y, Matsuda T, Sakakibara M, Mabe K, Nakajima S, Shimoyama T, Yasuda M, Kawai T, Murakami K, Kamada T, Mizuno M, Kikuchi S, Lin Y, Kato M. Prevalence of Helicobacter pylori infection by birth-year and geographic area in Japan. Helicobacter. 2014;19:105–10.
17. Watanabe M, Ito H, Hosono S, Oze I, Ashida C, Tajima K, Katoh H, Matsuo K, Tanaka H. Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population. Cancer Sci. 2015;106:1738–43.
18. Tamura T, Morita E, Kondo T, Ueyama J, Tanaka T, Kida Y, Hori Y, Inoue S, Tomita K, Okada R, Kawai S, Hishida A, Naito M, Wakai K, Hamajima N. Prevalence of Helicobacter pylori infection measured with urinary antibody in an urban area of Japan, 2008–2010. Nagoya J Med Sci. 2012;74:63–70.
19. Hirayama Y, Kawai T, Otaki J, Kawakami K, Harada Y. Prevalence of Helicobacter pylori infection with healthy subjects in Japan. J Gastroenterol Hepatol. 2014;29(Suppl 4):16–9.
20. Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E. Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. J Gastroenterol. 2011;46:1353–60.
21. Okuda M, Osaki T, Lin Y, Yonezawa H, Maekawa K, Kamiya S, Fukuda Y, Kikuchi S. Low prevalence and incidence of Helicobacter pylori infection in children: a population-based study in Japan. Helicobacter. 2015;20:133–8.
22. Inoue S. Stratification of gastric cancer risk by H. pylori infection. In: Suzuki H, Warren R, Marshall B, editors. Helicobacter pylori. Tokyo: Springer Japan; 2016. p.169–179.